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ABSTRACT
OBJECTIVE: To evaluate indicators related to the rational use of medicines and its associated 
factors in Basic Health Units.
METHOD: This is a cross-sectional study carried out in a representative sample of Brazilian 
cities included in the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de 
Medicamentos – Serviços, 2015 (PNAUM – National Survey on Access, Use and Promotion of 
Rational Use of Medicines – Services, 2015). The data were collected by interviews with users, 
medicine dispensing professionals, and prescribers; and described by prescription, dispensing, and 
health services indicators. We analyzed the association between human resources characteristics 
of pharmaceutical services and dispensing indicators.
RESULTS: At national level, the average number of medicines prescribed was 2.4. Among the 
users, 5.8%  had antibiotic prescription, 74.8% received guidance on how to use the medicines 
at the pharmacy and, for 45.1% of users, all prescribed medicines were from the national list of 
essential medicines. All the indicators presented statistically significant differences between the 
regions of Brazil. The dispensing professionals that reported the presence of a pharmacist in the 
unit with a working load of 40 hours or more per week presented 1.82 more chance of transmitting 
information on the way of using the medicines in the dispensing process.
CONCLUSION: The analysis of prescription, dispensing, and health services indicators in the 
basic health units showed an unsatisfactory proportion of essential medicines prescription and 
limitations in the correct identification of the medicine, orientation to the patients on medicines, 
and availability of therapeutic protocols in the health services. 
DESCRIPTORS: Drug Utilization, statistics & numerical data. Quality Indicators, Health Care. 
Management Indicators. Pharmaceutical Services. Primary Health Care. Health Services Research. 
Unified Health System.
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INTRODUCTION
Rational use of medicines requires users to use the appropriate medicine for their clinical 
condition in doses that meet their individual health needs, during an appropriate period 
and at the lowest cost to themselves and the community20.
The non-rational use of medicines may have a negative impact on population health, 
including avoidable adverse events and microbial resistance24. Adverse medicine events 
are estimated to account for 3.5% of hospital admissions6. According to one study, the 
occurrence of these events resulted in health services expenditure of about $ 21 million per 
100,000 adult population11.
The evaluation of the activities of Pharmaceutical Services (PS) is fundamental to promote 
the access and rational use of medicines. To assist in the PS evaluation, the World Health 
Organization (WHO) has developed indicators that can be used reproducibly so that methods 
are reliable and comparable across different studies and locations15. According to a document 
published in 2007, PS monitoring and evaluation can be performed at three levels. Level I 
concerns aspects of structure and organization process of the pharmaceutical industry. Level 
II targets the results of the national drug policy and is measured in public and private services 
and in households, in addition to the domains of access, quality, and rational use of medicines. 
The evaluation is conducted by a survey based on visits to state and municipal pharmacy supply 
centers; to public health units that perform ambulatory care and dispensing of medicines; and 
to private pharmacies of retail trade, being adaptable to the type of study that will be conducted. 
Level III details specific aspects of the organization of the pharmaceutical sector23.
According to a systematic review involving 900 studies conducted in 104 countries, the 
analysis of indicators on the rational use of medicines indicated that the inappropriate use of 
pharmaceuticals remains a public health problem12. This review included studies performed 
in public primary health care services. A similar scenario was observed in a multicenter 
study conducted in Brazil in 2004, which observed 40.1% of antibiotic prescriptions, 6.9% 
of injectable medicines, and 78.3% of medicines present in the list of essential medicines9,16. 
To evaluate the rational use of medicines in Brazil, current data are needed, from a 
representative sample of the Brazilian population that uses Unidades Básicas de Saúde 
(UBS – Basic Health Units).
The Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos – 
Serviços (PNAUM – National Survey on Access, Use and Promotion of Rational Use of 
Medicines – Services) aimed to characterize the organization of pharmaceutical services 
in the primary care of the Brazilian Unified Health System (SUS) – to promote the access 
and rational use of medicines –, as well as to identify and discuss the factors that interfere 
in the consolidation of pharmaceutical services in the cities. 
This study integrates PNAUM – Services and aims to evaluate indicators related to the 
rational use of medicines in the UBS and its associated factors.
METHODS
This study is part of PNAUM – Services, a cross-sectional, exploratory, evaluative study, 
composed of a survey of information in a representative sample of cities, primary health care 
services, users, physicians, and professionals responsible for dispensing of medicines in the five 
regions of Brazil. The sampling plan considered the several study populations and estimated the 
various sample sizes for each of these populations1. The sample size was estimated by algebraic 
expressiona. The sample sizes adopted in each region were 120 municipalities, 300 health 
services, and 1,800 users. The sample was stratified in capitals (26 and the Federal District); 
biggest cities (0.5% biggest cities in the region, totaling 27) and smallest cities (546 cities chosen 
by lot). From these 120 selected municipalities, 60 were selected by region, totaling 300 in the 
a The sample was estimated 
by the algebraic expression 
n0 = .deff
P(1-p)
(d/z)2 , where: 
P = 0.50 is the proportion of 
individuals to be estimated for 
being the one that leads to the 
largest sample size; Z = 1.96 is 
the value in the reduced normal 
curve for the 95% confidence 
intervals; deff is the effect of the 
design; d is the sampling error in 
percentage points. 
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country, in which the health services were chosen by lot. Health posts, health centers or UBS, 
and mixed units were included in the lot, according to the Cadastro Nacional de Estabelecimentos 
de Saúde (CNES – National Register of Health Establishments).
Face-to-face interviews were conducted with users, physicians, and those responsible for 
dispensing of medicines in the primary health care services, as well as telephone interviews 
with those responsible for pharmaceutical services in the cities, using a structured 
questionnaire specific to each category. The observation of the facilities of pharmaceutical 
services and availability of medicines were verified by observation script. A manual and a 
glossary of technical terms were developed for each research instrument. After the training 
of the interviewers, a pretest was carried out, involving cities with different population 
sizes, aiming to validate and improve the instruments. The data were collected from July 
2014 to May 2015. 
PNAUM considered as dispensers the professionals responsible for delivering the medicines 
to users, who may be pharmacists, nurses, nursing assistants, pharmacy assistants, or other 
professional category. 
The data were described by prescription, dispensing, and health services indicators, outlined 
for the study. The list of indicators and the criteria for their calculation were based on those 
recommended by the WHO to evaluate the rational use of medicines23, with adaptations and 
propositions carried out by the researchers (Table 1). The option of using indicators based 
on those recommended by WHO was performed to allow the comparison of PNAUM results 
with those obtained by national and international studies.
Table 1. List of prescription, dispensing, and health services indicators related to the rational use of medicines. National Survey on Access, 
Use and Promotion of Rational Use of Medicines – Services, 2015. 
Indicator Criteria for Calculation
Prescription
Average number of prescription medicines
We considered the number of medicines used by users who had at least one medicine 
prescribed by a doctor or dentist for the calculation of the average.
Proportion of users with antibiotic prescription
We considered the number of users who used at least one antibiotic as numerator and 
the number of users who used at least one medicine prescribed by a doctor or dentist 
as denominator. We considered as antibiotics the bacteriostatic and bactericidal 
antibacterial medicines, in systemic and topical use presentations. We considered 
the following categories in the Anatomical-Therapeutic-Chemical classification level 
(ATC): D06A-Antibiotics for topical use, D06BA-Sulfonamides, D06C-Antibiotics 
and chemotherapeutics combinations, J01-Antibacterials for systemic use, and 
J04-Antimycobacterials.
Proportion of users with injectable prescription
The numerator was the number of users who used at least one injectable medicine and 
the denominator was the number of users who used at least one medicine prescribed 
by a doctor or dentist.
Proportion of users with all prescribed medicines present in 
the national list of essential medicines
The numerator was the number of users with all prescribed medicines present in the 
National List of Essential Medicines of 2013, in force during the period of data collection. 
The denominator was the number of medicines prescribed by a doctor or dentist.
Dispensing
Percentage of professionals dispensing medicines identified 
with name and dose
We considered the number of professionals who reported dispensing medicines identified 
with name and dose as numerator and the number of professionals that act in dispensing 
medicines and who answered the questionnaire item on this topic as denominator.
Proportion of users who received guidance on medicines at 
the pharmacy
We considered the number of users who reported receiving guidelines on medicines 
at the pharmacy as numerator and the number of users who had at least one medicine 
prescribed by a doctor or dentist as denominator.
Health services
Availability of relevant therapeutic protocols in the medical 
offices, reported by physicians
We considered the number of doctors who reported the presence of relevant 
therapeutic protocols in the health units as numerator and the number of doctors 
interviewed as denominator.
Availability of a copy of the local or national list of essential 
medicines, reported by the dispenser
We considered the number of dispensing professionals who reported the availability of 
a copy of the local or national list of essential medicines in the unit as numerator and 
the number of dispensing professionals interviewed as denominator.
Source: PNAUM – Services, 2015.
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A descriptive analysis of the variables used in the study was performed. The indicators were 
described according to regions of Brazil. The comparison of the indicators between the regions 
was done with Chi-square test for the categorical variables and with ANOVA for the continuous 
ones. We analyzed the association between human resources characteristics of pharmaceutical 
services and indicators of dispensing related to the rational use of medicines by logistic 
regression, with calculation of the odds ratio (OR). We considered a 5% statistical significance 
level and 95.0% confidence interval. SPSS version 22.0 was used for statistical analyses. 
Participants signed an informed consent form. PNAUM – Services was approved by the 
National Research Ethics Committee of the National Health Council, by Opinion no. 
398.131/2013. 
RESULTS
PNAUM – Services interviewed 8,803 users, 1,585 doctors, and 1,139 professionals responsible 
for the dispensing of medicines in the UBS of the five regions of Brazil. Among the users, 
6,010 (68.3%) used at least one medicine prescribed by a physician or dentist and 4,890 
(55.5%) had at least one chronic disease. The proportion of medicines present in the Relação 
Nacional de Medicamentos Essenciais (Rename – National List of Essential Medicines) was 
55.2%. Table 2 shows the values of prescription, dispensing, and health services indicators 
related to the rational use of medicines. All indicators presented statistically significant 
differences between the regions. The average number of medicines prescribed in Brazil (2.4) 
was higher than the average value in the North (1.8), Midwest (2.0), and Northeast (2.2), but 
lower than in the South (2.9). The lowest proportion of users with antibiotic prescription was 
in the Southeast (3.8%) and the highest in the North (10.1%). The percentage of users who 
received guidance on medicines ranged from 71.4% in the South to 85.3% in the Midwest. 
The availability of a copy of Rename was reported by 80.5% of dispensing professionals in 
the North region and by 95.1% in the Southeast. 
Table 2. Prescription, dispensing, and health services indicators related to the rational use of medicines according to the Region of Brazil. 
National Survey on Access, Use and Promotion of Rational Use of Medicines – Services, 2015. 
Indicator Midwest Northeast North Southeast South Brazil p
Prescription
Average number of medicines prescribeda 2.0 2.2 1.8 2.2 2.9 2.4 < 0,01
Proportion of users with antibiotic prescriptiona (%) 6.6 5.4 10.1 3.8 6.9 5.8 < 0,01
Proportion of users with injectable prescriptiona (%) 5.8 4.8 8.1 6.0 6.5 6.0 < 0,01
Proportion of users with all prescribed medicines present in the 
national list of essential medicinesa (%)
47.0 45.6 46.5 52.2 38.7 45.1 < 0,01
Dispensingb
Percentage of professionals dispensing medicines identified 
by name and dose (%)b
65.7 64.8 65.4 72.5 69.4 67.4 < 0,01
Proportion of users who received guidance on medicines at 
the pharmacya (%)
85.3 80.5 80.9 72.9 71.4 74.8 < 0,01
Health services
Availability of relevant therapeutic protocols in medical 
offices, reported by physicians (%)
60.2 57.3 51.1 49.5 53.6 46.2 < 0,01
Availability of a copy of the local or national list of essential 
medicines, reported by the dispenser (%)
87.0 87.5 80.5 95.1 91.3 89.5 < 0,01
a Indicators calculated considering the number of patients who had at least one prescribed medicine as denominator (N = 6010)
b Calculated based on the professionals who answered the question 
Source: PNAUM – Services, 2015.
5s
Indicators of rational use of medicines Lima MG et al.
https://doi.org/10.11606/S1518-8787.2017051007137
The proportion of professionals who reported always transmitting information on how 
to use the medicines at the time of delivery of the pharmaceutical product was 90.9%. 
The dispensing professionals who participated in PS training in the two years prior to the 
interview had 1.49 more chance of dispensing medicines identified with name and dose 
(OR = 1.49, 95%CI, 1.36-1.62, p=0.00) and were less likely to provide guidance on how to 
use the products (OR = 0.86, 95%CI 0.77-0.96, p=0.01). The dispensing professionals whose 
units have full-time pharmacist were 1.82 times more likely to provide guidelines on the use 
of medicines (OR = 1.82, 95%CI 1.11-2.99, p=0.02). We observed no statistically significant 
association between dispenser performance in units with full-time pharmacist and 
dispensing of medicines identified with name and dose (OR = 1.17, 95%CI 0.67-2.03, p=0.58).
DISCUSSION
The analysis of prescription, dispensing, and health services indicators in the UBS pointed to 
aspects that should be considered in the consolidation of the Política Nacional de Assistência 
Farmacêutica (PNAF – National Policy of Pharmaceutical Services) to promote the rational 
use of medicines in primary health care. 
The mean number of prescribed medicines observed in this study (2.4) was similar to that 
found by a multicenter study conducted in Brazil in 20049 (2.3) and was higher than the range 
of values considered standard for the indicator (less than 2)7,22. A systematic review of studies 
conducted in Africa identified an average prescription of medicines of 3.114. In Brazil, this 
indicator presented significant regional variations, with 2.2 in the Northeast and 2.9 in the 
South, a situation that may be related to socioeconomic differences between regions. This 
result is in line with another cross-sectional study conducted in a sample of adult and older 
adult users of UBS, in which the prevalence of access to medicines for continuous use was 
higher in the South region than in the Northeast17. The authors attributed the difference to 
a higher proportion of users belonging to higher socioeconomic levels in the South17.  
The analysis of the frequency of antibiotic prescriptions is performed to assess their overuse23, 
which leads to microbial resistance in the population13. In this study, the proportion of patients 
with antibiotic prescriptions was 5.8%, lower than the average values of 37% for Latin America12 
and 46.8% for Africa13 observed in systematic reviews12,14. The value of this indicator was also lower 
than the established standard (less than 30%)7,22, suggesting that the proportion of antibiotic 
prescriptions is satisfactory in the UBS user population. In 2011, control of the dispensing of 
antimicrobial medicines was encouraged by the publication of RDC no. 20/2011 of the National 
Sanitary Surveillance Agency, which now requires retention of prescription in establishments 
dispensing products of this therapeutic class. Although the legislation regulates especially the 
dispensing process, we can assume that it has influenced the behavior of prescribers to increase 
caution regarding the prescription of antibiotics. However, this hypothesis and other possible 
factors associated with the use of antibiotics should be evaluated in a study outlined for this 
purpose. We observed regional variations in the proportion of antibiotic prescriptions, which 
was highest in the North region. This situation may have occurred because of the epidemiological 
profile of the region, with lower prevalence of chronic diseases compared to others with more 
favorable socioeconomic conditions, such as South and Southeast3. 
A systematic review of international studies showed a frequency of injectable medicines 
prescriptions of about 20%12. In this study, injectable medicines were prescribed to 6.0% 
of users, a value similar to the proportion observed by a Brazilian study carried out in 
three different states9. Because of the risk of complications for incorrect administration 
of parenteral medicines, the prescription of injectable products has been restricted to 
procedures performed in the UBS itself and to medicines that are not available in the oral 
form in pharmaceutical market, such as insulin.
The use of standardized lists of medicines in health systems contributes to the promotion 
of quality of care when products are selected according to criteria of health need, efficacy, 
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safety, quality, and cost22. In this study, the proportion of medicines present in Rename was 
55.2%, lower than that observed in Latin America (71.4%)12, Africa (88.0%)14, and in another 
Brazilian study9 (78.3%) carried out in 2004. The standard considered ideal for this indicator 
is 100%7, so that the proportion found by PNAUM – Services was unsatisfactory. 
We observed that, for 45.1% of users, all prescribed medicines were included in Rename. According 
to a study carried out in a region of China, the doctor’s knowledge about medicines was associated 
with a higher prescription of essential medicines19. Researches on factors associated with the 
prescription of essential medicines in the Brazilian context are needed to subsidize policies of 
permanent education for prescribing professionals in SUS. Despite the importance of adopting 
the relation of essential medicines for the rational prescription of medicines, the limitations of 
Rename should be emphasized. A Brazilian research related Rename’s medicines to studies of 
the Global Burden of Disease in Brazil10. According to an analysis done for Rename’s 2012 edition, 
some causes of disability-adjusted life years (DALY) have not been fully addressed by the medicines 
on the list, such as oral conditions, cancer, and psychiatric diseases10. 
The identification of medicines with name and dose at the time of dispensing was reported by 
67.4% of dispensing professionals. A Brazilian study pointed out that 95.2% of the medicines 
offered by SUS had data related to name, concentration, manufacturer, batch, and expiration 
period9. A study carried out in the primary health care of Botswana found that 74% of medicines 
dispensed at health posts were identified by name4. To ensure that the required amount of 
tablets is provided for the treatment of patients in the UBS, the blisters are cut, which leads 
to problems in medicine identification. The absence of identification of the pharmaceutical 
products in the primary packaging observed in this study can lead to medication errors, such 
as the use of expired medicines or exchange for another product by the user5. 
The dispensing of medicines involves patient orientations that contribute to the rational 
use of medicines, such as how to use them, time of treatment, major adverse reactions, 
and interactions with medicines and food13. The transmission of medicine guidelines is 
fundamental for the adherence to treatment and success of pharmacological therapy21. In 
our study, 74.8% of users reported having received information at the pharmacy on how 
to use the medicines, a proportion lower than that of a study conducted in a Brazilian city 
(92.5%)18. The professionals who reported the presence of a full-time pharmacist in the 
UBS had a greater chance of transmitting information to users. Dispensing professionals at 
Brazilian UBS may be pharmacists or assistants supervised by pharmacists or nurses. The 
presence and performance of the pharmacist in a weekly workload of 40 hours helps this 
professional so that he can guide or train assistants for the guidance on medicines.
The comparison of our results with others is difficult because of the differences in the 
adopted methodology: PNAUM questioned whether dispensers always delivered the 
medicines identified with name and dose to the patients. Dispensers who had PS training 
were more likely to dispense the medicines identified by name and dose, showing the 
importance of continuous health education actions for professionals involved in dispensing 
pharmaceuticals. In a contradictory way, professionals who participated in training were 
less likely to give guidance on how to use the medicines. This contradiction suggests that 
the training may have mainly addressed administrative procedures of dispensing as a matter 
of priority, but insufficiently the clinical aspects, such as patient orientation. However, this 
hypothesis must be tested by studies evaluating educational activities on the rational use 
of medicines regarding content, employed methods, and impact.  
The availability of a Rename was of 89.5%, similar to that found by a research carried out in health 
facilities in Saudi Arabia (90%)8 and lower than that observed by a study done in Pakistan (100%)2. 
However, the methodology used to estimate this indicator was different between the studies.
The therapeutic protocols are based on scientific evidence and reflect a consensus on the 
treatment of first choice for several clinical conditions, contributing to the promotion of 
rational prescription. In this study, 46.2% of physicians reported the availability of therapeutic 
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protocols in the medical offices. This indicator was not evaluated in recent studies of the 
literature, but a Brazilian study conducted in 2004 indicated the availability of protocols for 
the treatment of tuberculosis in 43.3% of health units9.
Among the limitations of the study, we highlight that the data on the accomplishment of 
medicines identification and orientation to the users in the dispensing process were collected 
by the professionals’ report and not by direct observation. The methodology used to estimate 
the indicators in PNAUM – Services differed in some situations from that used in other 
studies, which made it difficult to compare the results. Despite the limitations, our study 
presented an unprecedented panorama in the literature on the rational use of medicines in 
a representative sample of the UBS user population in Brazil.
Thus, we observed an unsatisfactory proportion of prescription of essential medicines and 
limitations in the correct identification of the medicine, guidance to patients on medicines, and 
availability of therapeutic protocols in the health services. The statistically significant difference 
in the values of the indicators between the regions of Brazil suggests that regional specificities 
should be considered in the formulation of policies aimed at increasing the rationality of the 
use of pharmaceuticals. The unsatisfactory proportion of prescription of essential medicines 
in the UBS points out the need for training SUS prescribers on the rational use of medicines. 
Regarding the dispensing process, educational activities for professionals of primary health care 
units and their supervision by full-time pharmacists may help users to use the right medicine 
for their clinical condition and have access to guidelines on their pharmacological treatment. 
Measures that qualify health, prescription, and dispensing services are needed to promote the 
rational use of medicines, which is one of the main goals of PNAF.
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